Astellas' sales up despite generic Prograf challenges
02 August 2011
Ian Haydock
Please Login to read the full article.
02 August 2011
Ian Haydock
ian.haydock@informa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- Astellas looks to Vesicare as growth saviour
- Roche hands Phase II diabetes candidate back to Chugai amid 'reprioritisation'
- Vesicare brings hope to Astellas as it looks to post-Prograf future
- Mirabegron approved in first market as Gardasil and Rotarix also get formal Japanese nod
EVENTS
Today
Le Plaza Hotel, Brussels, Belgium
Today
Diplomat Hotel, Prague, Czech Republic
Today
Business Design Centre, London
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
